Kuijper EJ - Search Results

1

Paradoxal Trends in Azole-Resistant Aspergillus fumigatus in a National Multicenter Surveillance Program, the Netherlands, 2013-2018.

Lestrade PPA, Buil JB, van der Beek MT, Kuijper EJ, van Dijk K, Kampinga GA, Rijnders BJA, Vonk AG, de Greeff SC, Schoffelen AF, van Dissel J, Meis JF, Melchers WJG, Verweij PE. Lestrade PPA, et al. Among authors: kuijper ej. Emerg Infect Dis. 2020 Jul;26(7):1447-1455. doi: 10.3201/eid2607.200088. Emerg Infect Dis. 2020. PMID: 32568033 Free PMC article.

2

Clostridium difficile: changing epidemiology and new treatment options.

Kuijper EJ, van Dissel JT, Wilcox MH. Kuijper EJ, et al. Curr Opin Infect Dis. 2007 Aug;20(4):376-83. doi: 10.1097/QCO.0b013e32818be71d. Curr Opin Infect Dis. 2007. PMID: 17609596 Review.

3

Novel risk factors for Clostridium difficile-associated disease in a setting of endemicity?

Goorhuis A, van Dissel JT, Kuijper EJ. Goorhuis A, et al. Among authors: kuijper ej. Clin Infect Dis. 2008 Aug 1;47(3):429-30; author reply 430-1. doi: 10.1086/589928. Clin Infect Dis. 2008. PMID: 18605911 No abstract available.

4

Spectrum of Clostridium difficile infections outside health care facilities.

Kuijper EJ, van Dissel JT. Kuijper EJ, et al. CMAJ. 2008 Oct 7;179(8):747-8. doi: 10.1503/cmaj.081211. CMAJ. 2008. PMID: 18838443 Free PMC article. No abstract available.

5

Azole-resistant central nervous system aspergillosis.

van der Linden JW, Jansen RR, Bresters D, Visser CE, Geerlings SE, Kuijper EJ, Melchers WJ, Verweij PE. van der Linden JW, et al. Among authors: kuijper ej. Clin Infect Dis. 2009 Apr 15;48(8):1111-3. doi: 10.1086/597465. Clin Infect Dis. 2009. PMID: 19272019

6

Clostridium difficile: controversies and approaches to management.

Bauer MP, van Dissel JT, Kuijper EJ. Bauer MP, et al. Among authors: kuijper ej. Curr Opin Infect Dis. 2009 Dec;22(6):517-24. doi: 10.1097/QCO.0b013e32833229ce. Curr Opin Infect Dis. 2009. PMID: 19738464 Review.

7

Rapidly growing mycobacteria: emerging pathogens in cosmetic procedures of the skin.

van Dissel JT, Kuijper EJ. van Dissel JT, et al. Among authors: kuijper ej. Clin Infect Dis. 2009 Nov 1;49(9):1365-8. doi: 10.1086/606051. Clin Infect Dis. 2009. PMID: 19814608 No abstract available.

8

[The rise of resistant gram-negative bacteria].

Kuijper EJ, van Dissel JT. Kuijper EJ, et al. Ned Tijdschr Geneeskd. 2010;154(45):A2868. Ned Tijdschr Geneeskd. 2010. PMID: 21118590 Review. Dutch.

9

Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009.

van der Linden JW, Snelders E, Kampinga GA, Rijnders BJ, Mattsson E, Debets-Ossenkopp YJ, Kuijper EJ, Van Tiel FH, Melchers WJ, Verweij PE. van der Linden JW, et al. Among authors: kuijper ej. Emerg Infect Dis. 2011 Oct;17(10):1846-54. doi: 10.3201/eid1710.110226. Emerg Infect Dis. 2011. PMID: 22000354 Free PMC article.

10

Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature.

Camps SM, van der Linden JW, Li Y, Kuijper EJ, van Dissel JT, Verweij PE, Melchers WJ. Camps SM, et al. Among authors: kuijper ej. Antimicrob Agents Chemother. 2012 Jan;56(1):10-6. doi: 10.1128/AAC.05088-11. Epub 2011 Oct 17. Antimicrob Agents Chemother. 2012. PMID: 22005994 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

491 results

Search Page

Filters